Poland· PL-100528923

Efracea

A doxycycline product containing doxycyclinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC J01AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEfraceaATCJ01AA02REGISTER NO.PL-100528923PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Doxycycline is registered in 16 of 19 countries.

Countries holding a registration under ATC J01AA02 (doxycycline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Doxycycline · ATC J01AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of doxycycline costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.27 in Italy to $1.54 in Switzerland — a ×5.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Doxycycline · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.54
  • CZ Czechia$0.98
  • IT Italy$0.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Doxycyclinum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
J01AA02
ATC class
Doxycycline
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991589370
  • gtin
    05909991589387

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

613 interactions on record for doxycycline.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Doxycycline · interactions on record

613 records

  • 11 severe
  • 143 moderate
  • 35 minor
  • 368 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe

56 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxycycline in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxycycline products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Doxybene, Doxycyclin G.L
  • Belgium · Doxycycline Eg, Doxycycline Sandoz
  • Bulgaria · Вибрамицин, Доксициклин Tzf
  • Cyprus · Doxat, Medomycin
  • Czechia · Deoxymykoin, Doxybene
  • Germany · Doxakne Tabs, Doxy
  • Denmark · Doxycycline Macure, Oracea
  • Estonia · Adoxtar, Doxy-M
  • Spain · Dosil, Doxiciclina Normon
  • Finland · Doximed, Doximycin
  • France · Doxy, Doxycycline Arrow
  • United Kingdom (Northern Ireland) · Doxycycline, Doxycycline Accord-Uk
  • Greece · Oracea, Smilitene
  • Croatia · Doksiciklin Belupo
  • Hungary · Doxitidin, Doxycyclin Al
  • Ireland · Doxycycline Activase Pharmaceuticals, Doxycycline Athlone Pharmaceuticals
  • Iceland · Doxycyklin Eql Pharma, Doxylin
  • Italy · Bassado, Doxynor
  • Liechtenstein · Ligosan
  • Lithuania · Adoxtar, Doxitin
  • Luxembourg · Doxycycline Eg, Doxycycline Sf Ratiopharm
  • Latvia · Doxitin, Doxy-M
  • Malta · Doxat, Doxycycline Activase
  • Netherlands · Doxycycline Accord, Doxycycline Disp Teva
  • Norway · Doksycyklin Hexal, Doxycycline Macure
  • Portugal · Actidox, Adoxtar
  • Romania · Doxiciclină Arena, Doxiciclina Atb
  • Sweden · Doxycycline Macure, Doxycyklin Eql Pharma
  • Slovenia · Doksivibra
  • Slovakia · Deoxymykoin, Doxyhexal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c981b867-cff6-4473-8353-ff5284005f2d
GET /v1/drugs/c981b867-cff6-4473-8353-ff5284005f2d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki o zmodyfikowanym uwalnianiu, twarde",
  "source": "urpl",
  "strength": "40 mg",
  "packaging": "05909991589370 ¦ Rp ¦ 164865\n28 kaps.\n05909991589387 ¦ Rp ¦ 164866\n56 kaps.",
  "substance": "Doxycyclinum 40 mg",
  "common_name": "Doxycyclinum",
  "pl_product_id": "100528923",
  "pozwolenie_nr": "374/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-11-25"
}

See everything about doxycycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.